CFR Pharmaceuticals
Avenida Pedro de Valdivia 295, Santiago, Metropolitana, 7500524, Chile
Overview
CFR Pharmaceuticals is a leading multinational pharmaceutical company with operations in 15 countries in Latin America (mainly Chile, Peru, Argentina and Colombia), and other emerging markets. Its business model is focused on the development, manufacture and commercialization of branded generics specialty products. The company manages its operations along several business segments including: Drugtech (neurology, psychiatry and cardiology), Gynopharm (women's health), Recalcine (acute therapeutic areas), Biomedical Sciences (monoclonal antibodies and treatments related to transplants, dialysis, oncology and rheumatology), Complex Injectables (sterile injectable products and lyophilized forms, for anesthesia, infectious diseases, cardiology and critical care); among others.
- Total investments
- 1
- Lead investments
- 1
- Investments · 12mo
- 0
- Active investors
- 0
Sector focus
- Biotechnology
- Manufacturing
- Pharmaceutical
Investment portfolio
- Uman Pharma
Led · Equity · Nov 2011
Uman Pharma develops and manufactures cytotoxic and high‑potent sterile injectable and solid dosage products for the oncology market, offering both proprietary and generic formulations. The company operates a manufacturing site in Candiac, Canada, where it produces specialized oncology products. Uman’s product focus is on high‑value, regulated oncology medications that require specialized sterile manufacturing. The recent equity investment will finance a substantial increase in the number of specialized oncology products developed and manufactured in Candiac for commercialization worldwide. Management expects to leverage the investor’s commercial capabilities to expand reach into regulated markets. The company’s core operations remain centered on sterile oncology product development and contract manufacturing.
Team
No current team members are available.